Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.42 |
| ▸ | MVD | P53602 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307946 | 0.92 | MEN1 (0.37) | LPAR3LPAR2LPAR1GAAP2RY10 | |
| SCHEMBL1900350 | 0.89 | LPAR3 (0.52) | LPAR3LPAR2LPAR1MVDLPAR5 | |
| SCHEMBL19986467 | 0.88 | LPAR3 (0.40) | LPAR3LPAR2LPAR1LPAR5P2RY10 | |
| SCHEMBL26848345 | 0.88 | PLA2G2A (0.38) | LPAR3LPAR2LPAR1P2RY10 | |
| SCHEMBL12733319 | 0.82 | LPAR3 (0.50) | LPAR3LPAR2LPAR1LPAR5GAA | |
| SCHEMBL26434943 | 0.80 | LPAR3 (0.38) | LPAR3LPAR2LPAR1 | |
| SCHEMBL17052668 | 0.79 | MEN1 (0.39) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL4528254 | 0.78 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL4528918 | 0.78 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR5 | |
| SCHEMBL4532022 | 0.78 | LPAR3 (0.64) | LPAR3LPAR2LPAR1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150343090-A1 | INTRACELLULAR DELIVERY SYSTEM AND METHODS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150343090-A1 | INTRACELLULAR DELIVERY SYSTEM AND METHODS | LNPEP, CHERP, CHMP4B | LPAR3 1412/4885LPAR2 1382/4885LPAR1 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.